Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review
- PMID: 33859621
- PMCID: PMC8042389
- DOI: 10.3389/fendo.2021.657889
Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review
Abstract
Background: Polycystic ovary syndrome (PCOS) is the most common cause of infertility in reproductive-age women. Insulin increases steroidogenesis, deranges granulosa cell differentiation, and affects follicle growth. However, results from randomized control trials (RCTs) were heterogeneous, and little strong evidence associated actual achievement of insulin sensitivity (IS) improvement with reproductive outcomes.
Objectives: To identify evidence of the reproductive benefit of IS improvement in infertile PCOS women by analyzing eligible RCTs.
Search strategy: Different search strategies with unlimited keywords, including treatment, therapy, intervention, polycystic ovary syndrome/PCOS, insulin resistance, pregnancy, conceive, live birth, and randomized controlled trials/RCT were used in databases including Pubmed, Embase, and Web of Science to November 20th, 2021.
Data collection and analysis: Two authors independently abstracted study details and assessed study quality.
Main results: Ten RCTs that covered different races and met the inclusion criteria were included for analysis and discussion. Clinical pregnancy rate was increased in infertile PCOS women when they had significant improvement of IS after treatment regardless of the various interventions (non-surgical). The benefits of IS improvement appeared superior in PCOS women without severe obesity. The effect of IS improvement on pregnancy rate was independent of the change of BMI.
Conclusions: Nonsurgical therapeutic strategies that promote superior IS improvement may aid infertile PCOS women to increase their possibility of successful pregnancy regardless of the various interventions. The improvement of IS might be more important than the reduction of BMI in the improvement of pregnancy rate in infertile PCOS women.
Keywords: insulin sensitivity; insulin sensitizers; polycystic ovary syndrome (PCOS); randomized controlled trials (RCT); review – systematic.
Copyright © 2021 Liu, Li, Yan, Liu, Ma and Tong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.Hum Reprod Update. 2019 Nov 5;25(6):717-732. doi: 10.1093/humupd/dmz029. Hum Reprod Update. 2019. PMID: 31647106
-
Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.Hum Reprod. 2004 Nov;19(11):2474-83. doi: 10.1093/humrep/deh440. Epub 2004 Sep 9. Hum Reprod. 2004. PMID: 15358717
-
Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.Acta Obstet Gynecol Scand. 2004 Jul;83(7):614-21. doi: 10.1111/j.0001-6349.2004.00481.x. Acta Obstet Gynecol Scand. 2004. PMID: 15225184 Review.
-
Individualized lifestyle intervention in PCOS women (IPOS): a study protocol for a multicentric randomized controlled trial for evaluating the effectiveness of an individualized lifestyle intervention in PCOS women who wish to conceive.Trials. 2023 Jul 18;24(1):457. doi: 10.1186/s13063-023-07466-y. Trials. 2023. PMID: 37464435 Free PMC article.
-
Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.Front Endocrinol (Lausanne). 2021 Feb 25;12:571229. doi: 10.3389/fendo.2021.571229. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716958 Free PMC article.
Cited by
-
Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review.BMC Endocr Disord. 2023 Nov 8;23(1):245. doi: 10.1186/s12902-023-01500-5. BMC Endocr Disord. 2023. PMID: 37940910 Free PMC article.
-
A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial.Avicenna J Phytomed. 2024 May-Jun;14(3):278-288. doi: 10.22038/AJP.2023.23122. Avicenna J Phytomed. 2024. PMID: 39086865 Free PMC article.
-
Treatment Options for Managing Anovulation in Women with PCOS: An Extensive Literature Review of Evidence-Based Recommendations for Future Directions.Life (Basel). 2025 May 27;15(6):863. doi: 10.3390/life15060863. Life (Basel). 2025. PMID: 40566517 Free PMC article. Review.
-
Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice.Hormones (Athens). 2024 Mar;23(1):49-58. doi: 10.1007/s42000-023-00494-y. Epub 2023 Oct 4. Hormones (Athens). 2024. PMID: 37792213 Review.
-
Polycystic Ovary Syndrome prevalence and associated sociodemographic risk factors: a study among young adults in Delhi NCR, India.Reprod Health. 2025 Apr 28;22(1):61. doi: 10.1186/s12978-025-02019-9. Reprod Health. 2025. PMID: 40296029 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous